Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × Pneumonia × Clear all

Phase

Status

Completed 12 Terminated 4 Recruiting 4 Unknown 3 Not yet recruiting 2 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 35 Prostatic Neoplasms 23 Breast Neoplasms 23 Colorectal Neoplasms 18 Carcinoma, Non-Small-Cell Lung 16 Neoplasm Metastasis 15 Lung Neoplasms 14 Pancreatic Neoplasms 13 Melanoma 13 Brain Neoplasms 13 Leukemia, Myeloid, Acute 12 Glioblastoma 12 Ovarian Neoplasms 10 Stomach Neoplasms 9 Carcinoma, Hepatocellular 9 Myelodysplastic Syndromes 8 Multiple Myeloma 8 Glioma 8 Triple Negative Breast Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Carcinoma, Renal Cell 7 Leukemia 6 Rectal Neoplasms 5 Pain 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma 5 Head and Neck Neoplasms 5 Esophageal Neoplasms 5 Uterine Cervical Neoplasms 4 Motor Activity 4

Interventions

Prednisone 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡